A recent report showed significant associations between several SNPs in a previously unknown EST cluster with schizophrenia. 1 The cluster was identified as the human dystrobrevin binding protein 1 gene (DTNBP1) by sequence database comparisons and homology with mouse DTNBP1.
Introduction
Family, 1,2 twin 3-5 and adoption 6, 7 studies suggest that genetic factors play a major role in the etiology of schizophrenia. The mechanisms are likely to be complex. Mendelian patterns of transmission are rare and perhaps nonexistent. 8 In total, 17 complete or nearly complete genome scans for schizophrenia have now been published. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] None of these scans have revealed large single-gene effects. Concordance rates for schizophrenia in monozygotic twins are far short of 100% stressing the importance of environmental factors. The abuse or dependence of certain psychoactive substances abuse or the presence of certain medical disorders can produce clinical states that resemble schizophrenia, suggesting that an unknown proportion of cases may be phenocopies. 25 Finally, schizophrenia could be heterogeneous, with different susceptibility loci influencing liability in different families. 26, 27 As part of the worldwide search for specific susceptibility genes, two reports from the Irish study of high-density schizophrenia families (ISHDSF) 28 presented evidence in support of the linkage of region 6p24-21 to schizophrenia and schizophrenia-related disorders. 28 The greatest LOD was 3.51 for marker D6S296. Other significant linkage signals involved D6S274 and D6S285. We are aware of eight explicit replication attempts. Although the precise meaning of 'replication' for linkage to a complex trait remains uncertain, 30, 31 three of these studies provide supportive evidenceFof variable strengthFfor a susceptibility locus in this region. Schwab et al. 32 found a multipoint affected sib-pair maximum LOD of 2.2 near D6S274 and À2.0 at D6S296. Maziade et al. 33 found supportive evidence for a schizophrenia susceptibility locus in this region in some but not all families. Lindholm et al. 34 found a maximum LOD of 2.6 at D6S277 in a single branch of the large pedigree indicating possible heterogeneity within the family; a haplotype comprising markers from D6S309 to D6S1578 was found to segregate with schizophrenia. Other replication attempts failed. [35] [36] [37] [38] [39] A collaborative multicenter study, which included most of the samples of schizophrenia families held around the world, found increased allele sharing of 55.9% and a multipoint maximum likelihood score (MLS) of 2.19 (P ¼ 0.001) excluding the ISHDSF and 2.68 (P ¼ 0.0004) including the ISHDSF families. 40 Two meta-analyses provided strong support for linkage to several markers in the 6p region, 41, 42 one did not. 43 In a follow-up study of the linkage signal in the ISHDSF, family-based association analyses were performed using SSLP and SNP markers. 44 In the 6p22.3 region, several SNPs in an unknown EST cluster appeared to be associated with schizophrenia. Full-length cDNA was obtained for the gene predicted by the EST cluster between markers D6S260 and D6S1676 by PCR from human brain cDNA libraries. 45 The sequence was identified as the human dystrobrevin binding protein 1 gene (DTNBP1) by sequence database comparisons and homology with mouse DTNBP1. 46 Genome annotation revealed that human DTNBP1 spans 140 kb and has a putative promoter with features characteristic of housekeeping genes. A total of 10 exons in our transcript were verified by direct sequencing. The corresponding cDNA is 1349 bp. The open reading frame encodes a 351-amino-acid protein that contains several conserved features: a coiled-coil region, a leucine-rich repeat and several protein kinase phosphorylation sites. The relation between genomic variation in dysbindin and the biological processes involved in schizophrenia is entirely speculative. 44 However, it is known to be expressed in the brain where it could, for instance, play a role in synaptic signaling and plasticity. Because it may be a component of the dystrophin complex, it could also be important for neuromuscular synapse formation and maintenance.
The linkage disequilibrium (LD) among the SNPs in DTNBP1 as well as the pattern of significant SNPschizophrenia association was complex raising several important questions. 44 For instance, SNPs p1635 and p1320 were both strongly associated with schizophrenia whereas two of the three SNPs located in the interval between p1635 and p1320 were not. This raised the question whether multiple susceptibility alleles are involved. Another example involves the complex pattern of LD. This made it very hard to determine the size of the area(s) and where the actual disease mutation(s) could be located, which is crucial for follow-up studies that attempt to identify the specific disease mutation(s). Finally, a considerable number of two-, three-and four-marker haplotypes showed significant association with schizophrenia. This made it difficult to determine the most optimal way to tag the disease mutation(s) and the choice of SNPs that would be most suitable to include in possible replication studies.
To address these questions, we first examined the patterns of significant SNP-schizophrenia associations using three different tests. In addition to the 12 SNPs studied previously, two more centromeric located markers in DTNBP1 were included in this study. In our pedigrees case-parents triads as well as sibling pairs are informative about disease-marker associations. The previous study relied exclusively on case-parents triads. In this article, we also used sibling pairs and performed tests that combine all available information in our pedigrees. We recently developed an automated SNP genotype scoring procedure. 47 Compared to genotype scoring by technicians, we estimated that this automated procedure reduced the number of genotyping errors by 1.6% and the number of missing genotypes by 3.3%. About 0.6% of the errors was the result of mistakes in the manual handling of the data, leaving 1% as the result of incorrect scoring. The 3.3% more missing genotypes were the result of errors in data handling (1.7%) and conservative scoring (1.6%). For the present analyses, all genotypes were rescored with this improved procedure. The previous study mainly focused on single-marker analyses. In this article, we used a variety of haplotype analyses to shed light on the patterns of LD and significant single-marker results. There is evidence suggesting that LD across the genome often shows a block pattern. [48] [49] [50] This pattern can be explained by the existence of a few common haplotypes that account for most of the haplotype diversity in the sample. Our first goal for the haplotype analyses was to determine the haplotype structure in the DTNBP1 gene to examine whether it provided an explanation for the pattern of LD. Next, tests were performed to examine whether a single or multiple high-risk haplotype was associated with schizophrenia. Finally, phylogenetic and geographic analyses were used to examine the population genetic history of possible high-risk haplotypes.
Methods

Sample and measures
Details of the study can be found elsewhere and here we confine ourselves to a short description. 28 The sample consisted of 268 multiplex families selected for high density of schizophrenia who were systematically ascertained from hospital sources in Ireland. This number may differ a little from those reported previously because families where there was uncertainty about the exact kinship relations were excluded from the present study. Most pedigrees consisted of two or three generations. The number of individuals in these pedigrees was 2368. The average number of children per nuclear families was 3.2. Genotypes from 1405 individuals were available.
Data collection included administration of the Structured Interview for DSM-III-R Diagnosis 51 and the Structured Interview for Schizotypy. 52 DSM-III-R diagnoses 53 were obtained using all available information (structured interviews, medical records, and family history report). The final diagnostic review was done by two experienced psychiatrists (KSK and DW) who were blind to genotypes and the diagnoses of relatives. Table 2 in the previous paper. 44 In addition to the 12 markers used in this previous study, two new markers were included in this study that were located centromeric from the other markers. The SNPs were identified via the SNP consortium and dbSNP databases plus a small-scale sequencing effort, where six pools of two cases each were sequenced in the exons and parts of the surrounding introns. No exonic SNPs were identified, but 7 intronic variants were, of which 4 performed well and had detectably high minor allele frequencies. Fluorescence-polarization detection with template-directed, dye-terminator incorporation (FP-TDI) was used for SNP genotyping 55 labeled. Several steps are involved:
PCR amplification: PCRs were performed in 10 ml volume containing 25 ng genomic DNA, 100 nM of each primer, 25 mM of each dNTP, 0.55 unit of TaqGold DNA polymerase, 2.1 mM MgCl 2 and 20 mM Tris-HCl, pH 8.5. Thermal cycling conditions used were: initial denaturation 10 min at 951C; followed by 10 cycles of touchdown PCR (951C for 45 s, 661C for 1 min with a 11C reduction in annealing temperature each cycle, 721C for 45 s.); followed by 40 cycles of 951C for 30 s, 581C for 45 s. and 721C for 1 min; and a final extension at 721C for 10 min.
Shrimp alkaline phosphatase (SAP) and Eescherichia coli exonuclease I (Exo I) digestion: After PCR, 6 m of enzyme mix containing 1 unit of SAP and 0.55 unit of Exo I were added to each sample. After brief centrifugation (1000 Â g for 1 min), the samples were incubated at 371C for 1 h and then 951C for 15 min to inactivate the enzymes.
TDI reaction: After enzymatic digestion, 6 ml of TDI mix was added to each sample. The TDI mix contains 8% glycerol, 50 mM Tris-HCl, pH 8.5, 5 mM MgCl 2 , 0.5 unit of thermosequenase, 1 mM TDI primer and 125 nM dye-labeled ddNTPs that are complementary to the polymorphic bases. The dye-labeled ddNTPs used are R6G-ddATP, R6G-ddTTP, ROX-ddGTP, TAM-RA-ddCTP and TAMRA-ddTTP. The thermal cycling conditions for the TDI reactions are 951C for 2 min, followed by 35 cycles of 951C for 30 s and 581C for 30 s.
The TDI reactions were read using an LJL fluorescence plate reader. For each dye used the reader generates an FP value for each sample. The genotypes were scored using an automated mixture model approach where genotypes that produced a conflict with the original manual scoring by technicians were re-scored by two raters. 47 Analysis of SNP haplotypes The disease mutation is introduced in the population on a specific haplotype background. 56 Because of recombination, the size of this ancestral haplotype is reduced considerably in course of time. However, recombinations may be more likely at specific locations, and the number of generations from the introduction of the disease mutation is not infinite. Individuals from different families will, therefore, still share part of the haplotype from a very distant common ancestor. These shared haplotypes are in fact the explanation for the LD observed between SNPs.
To determine the haplotype structure of the DTNBP1 gene, we first estimated haplotypes in our pedigrees using Simwalk. 57 Two nearby microsatellites (D6S260 and D6S1676) were included in these analyses to avoid ambiguity in a substantial proportion of the haplotypes. 58 Since these haplotypes are estimated in pedigrees of one to three generations, they will be much larger than those shared or preserved in a population of 'unrelated' individuals. To identify the part of the ancestral haplotypes that is preserved, we evaluated all possible combinations of adjacent SNPs using three criteria. In these analyses, we used the haplotypes of the pedigree founders only. Assuming the absence of recombination, all other haplotypes in the pedigree are only copies that do not contain new information but may disturb the analyses. For example, estimates of the frequency of the haplotypes would be affected by the size of the pedigrees. To avoid 'noise' as a result of estimation, genotyping error, and sampling error, we excluded families in which double recombinants were found and haplotypes that had a frequency less than 0.5% in the sample.
For SNP sequences that result in many different haplotypes and account for a modest proportion of all the diversity in the sample, it is likely that recombinations have occurred in the past so that the ancestral haplotype for this specific combination has not been preserved in the population. Our first two criteria were, therefore, the number of different 'common' haplotypes plus the total percentage of the haplotypes in the sample that was one of the common haplotypes. The third criterion was the frequency of the most common haplotype. The model assumes that within the preserved haplotype block, there have been no recombinations so that mutations in a 'wild type' are the main source of haplotype diversity. Finding a very common haplotype would be consistent with this model. If recombinations have occurred, it would be more likely to find multiple haplotypes that are common.
We used the program PAUP 59 to depict the evolutionary history of the haplotypes in a phylogram. The nodes in the phylogram are the haplotypes. The branches are drawn proportional to the number of inferred mutations. Assuming that the probability of mutation is equal for each SNP, longer branches are likely to be associated with longer time periods. Not all haplotypes in the phylogram have to be observed in the sample. For instance, an unobserved intermediate haplotype may be assumed to connect 2 observed haplotypes that differ by 2 mutations. The phylogram was estimated using the maximum parsimony algorithm that minimizes the number of mutations, or tree length, needed to account for observed haplotypes.
Another approach that may provide information about the history of haplotypes is to study their geographical distribution. If a high-risk haplotype would cluster in certain regions of the country it could be an indication that the disease mutation is fairly young and may have occurred after the population of Ireland was founded. As a first simple test we divided Ireland into four parts (the three provinces in the south plus Northern Ireland) and used a simple w 2 test for equal frequencies. The use of such a w 2 is, however, somewhat artificial because it is unlikely that differences in haplotype frequencies would correspond exactly with this geographic subdivision. We, therefore, also computed the frequencies of a high-risk haplotype in each of the 24 counties that were present in our sample and studied whether it clustered in certain geographic regions. For this purpose, we used the spatial correlation coefficient Geary's C (Cliff & Ord, 1981; Geary, 1954) , which is defined as A value less than 1 would indicate that counties that are located closer to each other are more similar with respect to the high-risk haplotype. A value of 1 for Geary's C implies no spatial correlation. Values greater than 1 are theoretically possible. However, they would not make sense in this context because it implies that counties that are close to each other are more different with respect to the frequency of the high-risk haplotype. This spatial correlation was calculated using the GRADAP package (Stokman & Sprenger, 1989) .
Results
Descriptive statistics and single-marker analyses Table 1 shows descriptive statistics and test results for the SNPs used in the present study. The position of the markers, measured in base pairs, relative to the 5 0 end of DTNBP1 as well as the exons are shown in column 2. The table shows that our map is somewhat less dense in the beginning (p1328 -p1655). Allele 60, 61 The markers in the middle (p1635 -p1792) all had frequencies below 0.20 (Mean ¼ 0.13) and were rarer than the other markers (Mean ¼ 0.39).
In our data, nuclear families as well as sib pairs can be informative about disease-marker associations. Informative nuclear families are ones in which there is at least one affected child, both parents are genotyped, and at least one parent is heterozygous. For any such triad, there is a pair of control alleles that has been 'vertically' transmitted to the affected child and a pair of alleles that has not been transmitted. If both parents are heterozygous, the minor allele can be preferentially transmitted twice; if one parent is heterozygous it can only be preferentially transmitted once. The number in the fourth column of Table 1 reports the total number of transmissions and the number in the fifth column the percentage of times the minor allele was preferentially transmitted to the affected child. The latter index ranges between -1 (the minor allele was never preferentially transmitted to the affected child) to 1 (the minor allele was always preferentially transmitted to the affected child). It provides a simple descriptive statistic for the evidence of association. Results for markers p1792, p1320, p1635, p1757, and p1765 show that, on average, 34.5% of all transmissions are in favor of the minor allele.
Informative discordant sibling pairs (DSPs) have at least one affected and one unaffected sibling with different marker genotypes. If the sibs are homozygous, the maximum number of 'horizontal transmissions' is 2 and if one is heterozygous and the other homozygous it is 1. The number in the sixth column in Table 1 reports the total number of transmissions and the number in the seventh column the percentage of times the minor allele was present in the affected sibling. It also ranges between -1 (the minor allele was never present in the affected sib) to 1 (the minor alleles was always present in the affected sib). These percentages of horizontal transmissions are fairly consistent with those for the vertical transmission. The average percentage of 22.3 is somewhat lower, marker p1635 shows less evidence for horizontal than vertical transmission, and marker p1763 showed evidence for horizontal transmission but only very modest vertical transmission.
Three tests were performed to examine whether the transmission of the minor allele was significant. All three tests are valid even when there is population substructure. The pedigree disequilibrium test (PDT) 62 considers both the horizontal and vertical transmissions. We computed the PDT test statistic by summing over all informative units. 63 The transmission disequilibrium test (TDT), 64, 65 only considers the vertical transmissions. It is a test for linkage with increased power in the presence of association. To perform the TDT, we used TRANSMIT. 60, 61 The first triad from each pedigree was selected to remove the dependency in the data and maximize the association signal compared to the linkage signal. 65, 66 TRANSMIT has the advantage that it can include triads with missing parental genotypes. This approach capitalizes on the fact that parent-child dyads may be informative about the genotype of the missing parent.
For instance, if a child and parent are both homozygous for the minor allele, the genotype of the missing parent must have at least one copy. Simulations have shown that by using dyads much of the loss in information caused by missing genotypes can be recaptured. 67 The final test was the sibling disequilibrium test (SDT) as implemented in the FBAT program. 68 This test only considers the 'horizontal' transmissions. The table shows that the three tests give fairly consistent results. All tests are significant at or close to the 5% significance level association for markers p1320, p1757, p1765, and p1635. Marker p1792 is not significant with the SDT. The explanation seems to be that most of the evidence comes from the vertical transmission, which will not be picked up by the SDT that focuses on horizontal transmission. Marker p1763 is nearly significant with the PDT but not with the others. Sampling error may be an explanation. However, the transmission evidence is consistent for this SNP so the PDT, which uses both types of transmission, may be more powerful for this marker.
In general, our results using multiple tests and a somewhat different genotype scoring were fairly consistent with those reported previously. 44 Differences were that p1655 was not significant anymore whereas p1765 was significant in our analyses. Marker p1635 appeared to yield the most significant results in the previous study that focused on vertical transmissions in parents-case triads only. As shown in Table 1 , evidence for horizontal transmission was more modest and there were other markers in our analyses such as p1320 that showed higher levels of preferential transmission. Finally, the new marker p1792 showed significant results suggesting that the association signals could be extended further in the centromeric direction.
Haplotype analyses
As a first step in studying the haplotype structure, we computed the LD between the SNPs using the measure d 2 , which is the squared correlation coefficient for a 2 Â 2 table. It is a good measure for studying haplotype structures because it can only reach its maximum of 1 if two alleles always occur on the same haplotypes. Other commonly used measures such as D 069 do not have this property and can also be 1 if one of the two alleles is present on other haplotypes as well. 70, 71 Results are reported in Table 2 . To help interpret the LD patterns we showed the full symmetric LD matrix and used a darker shading for cells that reported greater LD. Possibly because of the improved genotype scoring, the patterns of LD seemed somewhat clearer than reported previously. The table shows a block in the middle involving markers p1635 -p1792. These markers show considerable LD among each other but no substantial LD with the other markers in the DTNBP1 gene. The block is not completely homogeneous. Marker p1325 does not show any substantial LD, and LD is considerably lower for marker pairs involving p1578.
In Table 3 , we report the analyses aimed at determining the haplotype structure. Consistent with the LD results reported in Table 2, Table 3 suggests a haplotype block of 8 SNPs that range from p1635 to p1792. In this block, the 6 most common haplotypes account for 96.09% of all the founder haplotypes where 73.83% of the founders have the 'wild type'. This preferred structure is shown in the middle of the table. Directly above and below the preferred structure are two other 8 SNP long haplotype structures shifted 1 SNP to the right or left. Note that these haplotype structures give poorer results with respect to our criteria. For instance, the 8 SNP haplotype structure shifted to the left starting at p1655 results in 3 more haplotypes (9 instead of 6) that account for a lower percentage of the founder haplotypes (95.91% instead of 96.09%). Recombination may have occurred in this region resulting in a larger haplotype diversity. Furthermore, the most frequent haplotype is found in a much smaller proportion of the total sample (41.76% instead of 73.83%). This is not consistent with a model where there is a very common haplotype, and haplotype diversity is caused by mutations in this 'wild type'.
Increasing the haplotype length from 8 to 9 gave similarly poor results. On the other hand, decreasing the haplotype length to 7 did not improve the results. So, for the 7 SNP structure starting at p1635, there are still 6 haplotypes and the other criteria are only slightly better. Because the longer 8 SNP structure fits equally well, it was preferred on the basis of parsimony. That is, the total number of possible haplotypes equals 2 k where k is the number of SNPs. With 6 haplotypes, the ratio of number of observed haplotypes and total number of possible haplotypes is 4.69 for the 7 SNP structures and 2.34 for the 8 SNP structure.
Having determined the size of the block, we estimated the haplotypes using the two microsatellites and 8 SNPs in this block only, and performed significant tests to detect association with schizophrenia. Results are shown in A problem for TRANSMIT and the SDT is that the estimated haplotypes are not real observations (eg founders for whom no DNA is available will have an estimated haplotype). The PDT does not suffer from this problem because the observation is the sum of transmission in the whole pedigree. The PDT showed that the excess of transmission of haplotype 2 was significant. None of the other haplotypes showed significant results so that number 2 was the sole highrisk haplotype. Except for p1325 and p1578, this haplotype was determined by the minor alleles of the other SNPs in the 8 SNP block. The significant results for the individual markers reported in Table 1 can therefore be explained by the fact that they are all on the same high-risk haplotype. The minor alleles of p1325 and p1578 are not on this haplotype, which seems to explain the fact that these were the only two markers in the 8 SNP block that showed no significant effects in the single-marker analyses.
Another way to analyze haplotypes is to use TRANSMIT with the individual markers as input. Convergence problems were encountered when all 8 SNPs were analyzed. However, Table 4 suggests that the high-risk haplotype can be tagged by three sets of two SNPs: p1578 with p1757, p1578 with p1763, and p1578 with p1765. The reason is that the combination of the wild-type allele of p1578 and the minor allele of other marker occur on the high-risk haplotype only. For instance, the combination p1578 ¼ 1 and p1763 ¼ 2 is specific for the high-risk haplotype. TRANSMIT results were significant for each set: p1578-p1757:
Thus, all three sets show significant results confirming the PDT results indicating a significant effect of haplotype 2 on schizophrenia. Figure 1 shows the phylogram of the haplotypes from Table 4 . Although it is not possible to estimate its age, the main conclusion is that it is likely that the disease mutation may be of relatively recent origin in evolutionary terms. Several observations can be made with respect to the validity of the suggested evolutionary path. First, it often happens that there is no unique solution because multiple trees satisfy the maximum parsimony criterion. 72 However, in our case, there was a unique solution and only the tree reported in Figure 1 could account for the observed haplotypes by assuming 10 mutations. Second, in finding the best-fitting tree, we allowed for mutations (SNPs changing from 0 to 1) as well as back mutations (SNPs changing back from 1 to 0). Back mutations, however, are relatively rare. The fact that no back mutations had to be assumed in our best fitting tree therefore supported its validity. Another phenomenon is that it is rare for the same mutation to occur twice. In evolution this phenomenon is called homoplasy. In Figure 1 , the second SNP is mutated in haplotypes 3 and 6 and the first SNP is mutated in haplotypes 2 and 6. The consistency index (CI) is defined as m/s, where m is the minimum possible number of possible mutations, and s is the actual number of mutations assumed in the tree. This index hence varies from 1 (no homoplasy) to 0 (a lot of homoplasy). In our case, there are 8 SNPs, therefore m ¼ 8 and since the total number of mutations was s ¼ 10, for the tree in Figure 1 , we have CI ¼ 8/10 ¼ 0.8. CIs of 1.0 are rarely observed for phylogenetic tree and, although not perfect, the value 0.8 does seem acceptable. Another point is that both repeated mutations involved haplotype 4 which had a very low frequency in the sample. Sampling error in combination with the fact that the Simwalk estimates of the haplotypes can be wrong could therefore also be an explanation for the less than perfect CI. For the pediqu for whom the geographic location was known, Table 5 shows the total number of haplotypes, the percentage females, and the frequency of the high-risk haplotype in each county/ province. The table suggest a reasonable equal distribution across Ireland. In addition, the null hypothesis assuming equal frequencies of the high risk haplotype in the three provinces plus Northern Ireland could not be rejected (w 2 ¼ 3.294, df ¼ 3, P ¼ 0.348). The spatial correlation measuring the amount of clustering of this haplotype in specific geographic regions was 0.87. This value is very close to 1 and suggested at most a slight tendency for geographic clustering. Inspection of the table 
Discussion
A recent study in the ISHDSF showed a complex pattern of LD among SNPs in DTNBP1 as well as significant SNP-schizophrenia associations. This raised several questions such as the number of susceptibility alleles that may be involved and the size of the region where the actual disease mutation(s) could be located. To address the questions, we performed several single marker tests on the 12 previously studied and 2 new SNPs in DTNBP1 that were re-scored using an improved procedure, and also performed a variety of haplotype analyses. Results suggested a simple structure where the LD in the target region was mainly caused by 6 haplotypes that together accounted for 96% of haplotype diversity in the whole sample. A single high-risk haplotype was identified that explained the patterns of individual SNP-schizophrenia associations. The size of this haplotype was 30 kb and it was relatively rare. In evolutionary terms, the high-risk haplotype could be of recent origin and we found that it was equally distributed over Ireland.
Results from our analyses have several implications, most of which are relevant for follow-up and possible replication studies. The analyses suggested a 30 kb region, comprising the 5 0 -UTR and 5 0 -most 5 confirmed exons of DTNBP1, where the disease mutation could be located. This provides further support for the idea that the DTNBP1 gene is involved thereby excluding the neuronally expressed gene JMJ, which directly abuts DTNBP1 distally and showed no significant SNP-schizophrenia associations in the previous study. Proximally, there are no ESTs or consistently predicted exons for the next few hundred kilobases. Although this does not completely rule out genes being present there, it does make it more unlikely that the causal mutation is in this region. Furthermore, because there was no short-distance LD between markers in the high-risk haplotype and proximal SNPs, additional phenomena such as gene conversion would be needed to account for the implied large-distance LD in the absence of shortdistance LD. 73, 74 The SNPs that showed significant results are intronic and none is located in canonical splice sites. Although there is more to learn about a possible role of intronic sequences, it is questionable that any of our SNPs affect expression. Furthermore, because of the block structure it is unlikely that the use of statistical techniques will help us to get a more precise estimate of the disease location. That is, there is no way to study whether some segments of the high-risk haplotype are more or less associated with schizophrenia. The next step may, therefore, be to sequence exons in this 30 kb region to search for the disease mutation. Results from this study will be helpful to sequence more efficiently, because it allows us to identify a subgroup of affected individual who are more likely to have the disease mutation because they have the high-risk haplotype.
When both the vertical and horizontal transmissions were considered, the SNP p1320 gave the best results in the single-marker analyses and could be a candidate to be included in possible replication studies. However, in the present study all individual LD signals could be attributed to a single high-risk haplotype. The differences in the single-marker analyses may, therefore, merely reflect sampling error and it could be preferred to focus on the high-risk haplotype, which is a more specific indicator of the disease mutation. For this purpose, it is not necessary to type all 8 SNPs. Our analyses suggested three sets of two markers where combinations of their alleles were unique for the high-risk haplotype so that they are suitable as tag SNPs. Possibly, mainly because of sample fluctuations, the most significant results were obtained with the marker pair p1578-p1757. It may also be important to note that the suggested markers here differ from those reported previously exploring combinations of markers that showed excess of transmission. Assuming that the haplotype structure derived in this article is valid, the suggested tag SNPs in this article should be more optimal because they uniquely define the high-risk haplotype.
The use of our tag SNPs in other samples assumes that our haplotype structure can be generalized. Currently, there are little empirical data concerning the generalizability of these structures. It is important to realize, however, that the issue here involves the structure and not the haplotype frequencies. Differences in allele and haplotype frequencies are very common 75 but do not necessarily imply different haplotype structures. The few studies that are available do support the idea that haplotype structures can be generalized to other populations. Patil et al, 50 using a sample of 24 individuals from different parts of the world, found that more than 80% of this global sample could typically be characterized by only 3 common haplotypes. A recent study of LD across the whole of chromosome 22 for the Germans, Estonians, CEPH controls, and a set of data taken from a British population, found that the patterns were almost indistinguishable. 76 The average size of these blocks was 22 Kb and 4-6 haplotypes typically described over 90% of samples tested. This corresponded very well with our results. Gabriel et al 49 studied haplotype patterns across 51 autosomal regions (spanning 13 Mb of the human genome) in samples from Africa, Europe, and Asia. They found that the boundaries of blocks and specific haplotypes they contain are highly correlated across populations. On the other hand, there is ample evidence that LD is smaller in African samples 74 possibly because these are older populations where recombination may have had more time to reduce haplotype size. Thus, generalization to populations with very different demographic and population genetic histories could be problematic. Two observations are important for possible replication studies. First, the estimated frequency of the high-risk haplotype (6%) was rather low. This frequency is important because of its negative relation with power to detect association. For two reasons it is possible that the prevalence of the high-risk haplotype may even be lower in other samples. First, the families in this study came from high-density families, and it could be that the high-risk haplotype codes for a specific subtype of schizophrenia that is more prevalent in high-density families. Second, instead of suffering from specific subtypes, individuals from high density families may be more severely affected. The sampling of more extreme groups implies that causal factors will be at higher frequencies than in samples with less severely affected individuals. Thus, a higher prevalence of the high-risk haplotype would be expected if highdensity families suffer from a relatively more severe form of schizophrenia. Kendler et al 28 compared symptom levels in ISHDSF families vs an Irish epidemiological sample of schizophrenic probands. Affected members from the multiplex families did have a somewhat more chronic course and poorer overall outcome, but these differences were rather small. Although this does not exclude differences for specific causal factors, these results were not suggestive of the idea that multiplex families suffer from different subtypes or much more severe forms of schizophrenia.
A second observation that may be relevant for possible replication studies is that the high-risk haplotype seemed to have a large effect being preferentially transmitted in over 40% of the total number of transmission. Another way to express the effect size is in terms of relative risks. For this purpose, we fitted a genotype relative risk model 77 to estimate C 1 that represents the increased chance of being affected when an individual has one copies of the high-risk haplotype, and C 2 that represents the increased chance of being affected when an individual has two copies of the high-risk haplotype. The model was fitted using the program LEM that can include information from triads with missing haplotypes. 78 Because only four cases were homozygous for the high-risk haplotype, it was not possible to estimate C 2 reliably and we confined ourselves to a model where C 2 ¼ C 1 . The estimated effect size was C 2 ¼ C 1 ¼ 3.11, which again suggested a fairly large effect. These large effect sizes have a very favorable effect on power to detect the high-risk haplotype in other samples. However, effect sizes are affected by selection where a more extreme selection results in larger effect sizes. Thus, in a sample that differs in terms of severity from our high-density families effect sizes power will be lower.
We performed calculations to explore the sample sizes needed for approximately 80% power to replicate our findings in a sample of parents-case triads. For the sake of simplicity, we assumed that the haplotypes were estimated without ambiguity. With a 6% frequency, a Type I error of 5%, and an effect size of C 2 ¼ C 1 ¼ 3, sample sizes as small as 125 triads should approximately give the 80% power to reject the null hypothesis (C 2 ¼ C 1 ¼ 0) and detect the highrisk haplotype (C 2 ¼ C 1 4 1). Reducing the frequency to 3% did not have a dramatic effect and it should be possible to detect the high-risk haplotype in samples of 200 triads as long as the effect size is still 3. Altering the effect size had a larger effect. So reducing it to C 2 ¼ C 1 ¼ 2.25 would require about 225 triads with a frequency of the high-risk haplotype of 6% and further reduction to C 2 ¼ C 1 ¼ 1.5 results in a required sample size of 1025 triads.
The phylogram suggested that the high-risk haplotype was of relatively recent origin. It may be important to stress that this conclusion is only partly dependent on the validity of the phylogram. The disease mutation was present on a haplotype where most of the SNPs were mutated. Therefore, regardless of the precise evolutionary path, it can be argued that such haplotypes are likely to be younger than haplotypes with few mutations. The relatively recent origin does not mean that the diseases mutation on the high-risk haplotype occurred after the population of Ireland was founded. It may very well be introduced by a founder so that it can be expected to be present in other (European) populations as well. Although this is hard to test, we speculated that a true founder effect would be more consistent with the high-risk haplotype being distributed over the whole of Ireland. In contrast, if haplotype arose after the migration it may have been more prevalent in the region of the country where it originated. Our data suggested that the high-risk haplotype was distributed equally over Ireland. This supports the founder hypothesis and suggests that the disease mutation may not be specific for Irish families and could be found in other populations as well.
